IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Braslyn Ltd.

Q4 2023 Holdings

Filed 2024-02-14 | 3 holdings | $186.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Mirati Therapeutics Inc(MRTXEUR)Common60468T105$184.2M3,135,96699.0%
Inseego Corp(INSGEUR)Common45782B104$1.7M7,614,8300.9%
Tango Therapeutics Inc.(TNGX)Common87583X109$266.9K26,9610.1%